New patent for Vanda Pharms drug HETLIOZ LQ

Annual Drug Patent Expirations for HETLIOZ+LQ Hetlioz Lq is a drug marketed by Vanda Pharms Inc and is included in one NDA. It is available from one supplier. There are…
The post New patent for Vanda Pharms drug HETLIOZ LQ appeared first on DrugPatentW…


Drug Patent Expirations for the Week of June 12, 2022

CRESTOR (rosuvastatin calcium) Ipr Patent: 6,858,618 Expiration: Jun 17, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Drug Pate…


Biotechblog